» Articles » PMID: 10477091

Signaling Pathways Mediating Gastrin's Growth-promoting Effects

Overview
Journal Peptides
Specialty Biochemistry
Date 1999 Sep 7
PMID 10477091
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to its fundamental role in stimulating gastric acid secretion, the peptide hormone gastrin induces growth-promoting effects on diversity of target cells. Various mechanisms, including endocrine, paracrine, and autocrine, have been proposed for gastrin's growth-promoting actions. The mitogenic effects of gastrin are mediated by specific cell surface receptors activated after gastrin binding. The functionally defined receptors for gastrin include cholecystokinin A (CCKA) receptor, which is discriminating for sulfated CCK8; cholecystokinin B (CCKB)/gastrin receptor, which binds gastrin17 sulfated, and nonsulfated CCK8 with nearly equal affinities; cholecystokinin C (CCKC), which is a low-affinity gastrin binding protein; and novel, high-affinity receptors selective for amidated gastrin, processing intermediates of gastrin, or both. The signaling pathways mediating gastrin's stimulation of the CCKB/gastrin receptor have been progressively outlined, and the pathways mediating other receptors have been slowly emerging. Engagement of the gastrin receptor initiates various biochemical and molecular events, including recruitment and activation of tyrosine kinases, activation of the phospholipase C signaling pathway leading to phosphoinositide breakdown, intracellular calcium mobilization and protein kinase C stimulation, activation of the mitogen-activated protein kinase pathway, and induction of early response genes. Current emphasis is on understanding the functional significance of processing intermediate forms of gastrin, and the receptor subtypes and pathways that promote the trophic/mitogenic effects of the different molecular forms of gastrin.

Citing Articles

Long-Term Administration of Omeprazole-Induced Hypergastrinemia and Changed Glucose Homeostasis and Expression of Metabolism-Related Genes.

Kabaliei A, Palchyk V, Izmailova O, Shynkevych V, Shlykova O, Kaidashev I Biomed Res Int. 2024; 2024:7747599.

PMID: 38884019 PMC: 11178409. DOI: 10.1155/2024/7747599.


Proton pump inhibitors and colorectal cancer: A systematic review.

Patel A, Spychalski P, Antoszewska M, Regula J, Kobiela J World J Gastroenterol. 2021; 27(44):7716-7733.

PMID: 34908809 PMC: 8641055. DOI: 10.3748/wjg.v27.i44.7716.


Generation of 3D human gastrointestinal organoids: principle and applications.

Zhang M, Liu Y, Chen Y Cell Regen. 2020; 9(1):6.

PMID: 32588198 PMC: 7306834. DOI: 10.1186/s13619-020-00040-w.


Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.

Khan M, Huang T, Lin C, Wu J, Fan B, Bian Z Oncotarget. 2017; 8(61):104615-104637.

PMID: 29262666 PMC: 5732832. DOI: 10.18632/oncotarget.18403.


A hypothesis of couplet molecules and couplet cells in gastric function and an association with Helicobacter pylori.

Craven C BMC Gastroenterol. 2016; 16:16.

PMID: 26879837 PMC: 4754955. DOI: 10.1186/s12876-016-0429-0.